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3 publications, and reconciles 6,057 variants that have been reported in literature multiple times. VariCarta is freely accessible at http://varicarta.msl.ubc.ca.
Background
The genetics risk of ASD is based on the interplay between common inherited variants and rare, often de novo, variants. While the aggregated contribution of common variants is estimated to be high, ranging up to 50% (Klei et al., 2012; Gaugler et al., 2014) , their individual effect sizes are small and only a few common risk loci have yet been identified so far, partially due to the limited cohort sizes used in genome-wide association studies up to now (He et al., 2013a; Grove et al., 2017; Kosmicki et al., 2017; Vorstman et al., 2017) . On the other hand, rare variants with large effect sizes, such as copy-number variants or likely gene damaging single nucleotide variants (SNVs), were found in many ASD individuals; it is estimated that rare genetic variants, both de novo and inherited, are causal in at least 10-30% of cases (Iossifov et al., 2012 Sanders et al., 2015; Turner et al., 2017a; Vorstman et al., 2017; Yuen et al., 2017) . Consequently, most of the effort towards understanding the etiology of ASD in the last half a decade has gone into employing next-generation sequencing technology to identify rare, possibly causative mutations in ASD individuals.
There have been a few dozen whole exome sequencing (WES) or whole genome sequencing (WGS) studies of various ASD cohorts, reporting on identified variants and genes containing them. The overlap within and between the studies' findings at the gene and, especially, variant level has been limited, highlighting the genetic heterogeneity of the disorder. Thus a key strategy for identifying ASD candidate genes is to sequence 4 large numbers of individual genomes to identify likely impactful events, especially de novo mutations, recurring in the same gene in unrelated individuals (Buxbaum et al., 2012; Sanders et al., 2012a) . This approach resulted in the discovery of many ASD candidate genes. Current estimates for the total number of ASD-associated genes range from several hundreds to over a thousand (Iossifov et al., 2012 Sanders et al., 2012b Sanders et al., , 2015 He et al., 2013b; Ronemus et al., 2014) .
While the sequencing efforts continue, there is a need to aggregate and consolidate the findings. The analysis and reporting of variants across studies can vary in many respects, such as reference assembly, transcript set, variant calling and annotation software used, as well as the choice of variant nomenclature, and without careful curation and standardization they are not easily comparable and integrable (Deans et al.; McCarthy et al., 2014; Yen et al., 2017) . At the same time, some cohorts (or individuals within cohorts) have been repeatedly sequenced and analyzed, and the same variants have been reported multiple times across publications, but not necessarily in a consistent format. If pooled across studies, this can lead to double-counting and inflation of gene-based evidence for ASD association. With these challenges in mind, we developed VariCarta with the goal of collecting, reconciling and accurately cataloguing literature-derived ASD-associated variants. We employ precise, systematic curation of the data, standardized processing and reporting, identification of overlaps, and comprehensive annotation. The harmonized data is available to researchers for querying and download at http://varicarta.msl.ubc.ca.
5

Construction and content
We searched the literature for publications reporting rare genomic variants, SNVs and InDels, found in subjects with ASD diagnosis. We prioritized whole-genome and wholeexome studies (37) over candidate gene studies (13). Papers currently included in VariCarta are listed in Supplemental File 1.
For each publication, we applied the following curation procedures, with an intermediate goal of organizing all relevant variant information in a tabular format that is ready for import. The first step in this process is to copy the relevant text from the source file (typically a supplementary file) as-is in a template import document. The completed document is composed of a set of predefined worksheets, which contain the publication's metadata, variant data and a description of the steps needed to automatically extract, transform and load the data into a uniform variant data model. This document is parsed by a computational pipeline, which validates and stores the data into a relational database. The link to the pipeline's source code as well as an example import document are found at varicarta.msl.ubc.ca/downloads.
There are different variant reporting conventions used in in the literature, so careful inspection is needed to determine the format that was used in a publication, and steps needed to convert it into a standardized format VariCarta uses for displaying variants.
These steps are described in the import document and may include conversion of nongenomic to genomic variant coordinates using TransVar (Zhou et al., 2015) , biocommons UTA and HGVS packages (Hart et al., 2015) , UCSC liftOver of genomic coordinates to GRCh37/hg19 human genome assembly, conversion from zero-based to one-based 6 indexing system, correction of erroneous reference bases and so on. Once the genomic coordinates have been resolved and the uniform formatting has been applied, we use ANNOVAR (Wang et al., 2010) to annotate variants. This annotation includes gene-level information, such as genomic context, transcript accession number, and functional effect of the variant within the gene. We also include variant-level annotations using CADD (Kircher et al., 2014) for variant deleteriousness prediction and ExAC (Lek et al., 2016) for allele frequencies in the general population. At this stage, we exclude variants that are found in control subjects or subjects not reported to have an ASD diagnosis (for studies that report on cohorts with different neurodevelopmental phenotypes). Variants were excluded if they were reported as having failed to validate using an orthogonal sequencing technology, whose coordinates and/or reference alleles cannot be confidently disambiguated or were problematic for some other reason detailed in the curator notes.
Although the trend in ASD sequencing studies is to report mainly rare coding genomic variants, the final list of imported variants may include common and non-coding variants if these were present in the original report. These are easily distinguished based on ExAC frequencies or genomic context.
The last phase of variant processing is harmonization, which ensures that variant events are not double-counted. We define a "variant event" as a unique combination of a reference allele, its genomic location and alternative allele belonging to a single individual. We also define a "complex event" as a grouping of two or more variant events from the same individual that differ but have overlapping or adjacent genomic coordinates. This indicates that the grouped variant events might be describing the same underlying genotype but are incongruent due to the heterogeneity of formats used across papers. For example, the same several-base long substitution can get reported either as a single substitution variant or a series of SNVs.
Because subject IDs are used to define variant events, we take special care when handling cohorts that are already present in VariCarta to ensure that subject IDs between the studies are consistent. Occasionally, the same subject could have slightly different IDs between studies: for example, Yuen et al. 2015 (Yuen et al., 2015 uses "-" (dash), while Yuen et al. 2017 (Yuen et al., 2017 uses "_" (underscore) in otherwise identical subject IDs from the same cohort. Another example is the omission of "p1" suffix, meant to indicate a proband, from a Simons Simplex Collection (SSC) family ID in Iossifov et al. (2012) (Iossifov et al., 2012) , Iossifov et al. (2014) and Ji et al. (2016) (Ji et al., 2016) . We attempt to rectify such discrepancies during the curation stage. This is facilitated by the introduction of internal VariCarta-specific subject IDs that can be linked with more than one original study ID. However, we were not always able to resolve overlaps, such as in cases were subject IDs are not provided or are non-mappable to the original cohort identifiers. While these variants appear in the database as uniquely reported, the curation notes on the publication details page, would indicate the possibility of overlap. A two-base substitution found in SSC subject 14606.p1 has been reported in five different papers included in VariCarta. Iossifov et al. and Kosmicki et al. (Kosmicki et al., 2017) report it as two contiguous SNVs (C->A and C->G) at positions 134059281 and 134059282 on chr5, while Krumm et al. (Krumm et al., 2015) reports it as a non-frameshift substitution (CC->AG). Both representations describe the Clicking on a book icon in the Details column opens a page with more detailed information about the study, including methodology used, size and type of the cohort, and types of variants reported. We also provide curation notes, which detail issues that had to be resolved during the curation stage, or other noteworthy information regarding the study. Clicking on the variant event count will display all the variants from that publication that are available in VariCarta.
Utility and discussion
The Statistics page (varicarta.msl.ubc.ca/stats) offers several gene rankings based on different criteria. These rankings are not intended to be used for a prioritization of ASD candidate genes because they can include common variants (non-coding variant are 1 0 excluded from ranking calculations), as well as variants from targeted studies, which are typically excluded for the prioritization purposes. The Statistics page also shows the distribution of variants across publications, functional effects and genomic features.
Finally, it includes a heatmap of the variant overlap between publications (Figure 1) , which illustrates the extent of variant double-reporting across the literature. The variants reported in two different papers can be accessed by clicking on the overlap number in the heatmap.
Any VariCarta updates will be immediately available on the development version of the database (dev.varicarta.msl.ubc.ca), while the main site will be updated on regular bases. 
Comparison to similar resources
We are aware of three other public databases that collect ASD variant data from scholarly literature. One of them is considered to be ASD-specific (SFARI), while the other two are more general, containing de novo mutations associated with multiple phenotypes (denovo-db and NPdenovo).
The SFARI gene database, a licensed version of AutDB (Basu et al., 2009 ) by MindSpec, is a web portal for cataloguing ASD candidate genes. The central SFARI Human Gene module contains information about human genes that have been associated with ASD, relevant references from articles, and different kinds of genetic datasets that provide evidence for linking the genes to ASD and help categorize and score genes based on the strength of that evidence. These data include genetic variants, both rare and common, reported to be associated with the disease. However, the SFARI database is not entirely ASD-specific since many of the reported variants were found in subjects not diagnosed with ASD, but other disorders, such as intellectual disability, epilepsy and general 1 3 developmental delay. Since the SFARI variant table does not show the disease association, the access to ASD-specific variants is non-trivial. The variant annotation in SFARI also lacks transcript information and genomic coordinates, which makes it difficult to identify the exact genomic location of the variant and its predicted functional effect. Another concern is that, due to the multiple WES/WGS publications on the same cohorts of ASD individuals, some variants are reported more than once potentially leading to the inflation of the ASD-association evidence. Finally, the variant information in SFARI is not available for bulk download and thus cannot be used for any kind of high-throughput analysis.
denovo-db (Turner et al., 2017b ) is another database of germline de novo variants, not 
Discussion
Here we present VariCarta, a database of literature-derived genomic variants found in One way to address this problem, as adopted by denovo-db and NPdenovo, is to avoid studies reporting on a cohort that has been used in another already curated study. While this approach may work for the obvious cases of cohort overlaps, there are many partial and more complex overlaps between studies, as illustrated in Figure 1 , and consolidating these cases requires more systematic approach. In addition, studies that report on the same subjects, do not necessarily report the same variants, either due to differences in variant processing (e.g. applying different filters) or heterogeneity of variant reporting formats. Simply excluding variants from one of the studies can result in the omission of valuable information. Finally, linking variants to all the papers that report them is important for documenting data provenance and accessing additional information provided in the publication.
VariCarta puts special emphasis on harmonizing variants derived from the same cohorts of subjects by carefully linking the variants together, while still retaining the original publication and annotation data. Currently VariCarta contains 6,057 variants that have been reported more than once; some of them has been published in as many as nine papers (varicarta.msl.ubc.ca/variant?chr=20&start=49510027&stop=49510027).
Although we made a substantial effort to convert all variants into the same format sometimes the differences cannot be completely resolved; the example in Table 1 
Conclusions
To the best of our knowledge, VariCarta is the largest collection of systematically curated, harmonized and annotated literature-derived variants that is specific to ASD.
Although variants can go through multiple transformation steps as they are being converted to the VariCarta uniform format, these steps are documented and the original variant information is retained and readily accessible. Our curators are always on the lookout for new relevant publications, which are being continuously added to the database. While whole genome and whole exome studies are of primary interest, we will continue to add gene-targeted studies that are aligned with our research interests or requested by the research community. We hope that the ASD research community as well as clinicians working with ASD subjects will find VariCarta to be a useful resource.
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